Pischedda, F;
Cirnaru, MD;
Ponzoni, L;
Sandre, M;
Biosa, A;
Carrion, MP;
Marin, O;
... Piccoli, G; + view all
(2021)
LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation.
Brain
, 144
(5)
pp. 1509-1525.
10.1093/brain/awab073.
Preview |
Text
BRAIN-2020-01856.R1_Proof.pdf - Accepted Version Download (29MB) | Preview |
Abstract
Parkinson’s disease is characterized by the progressive degeneration of dopaminergic neurons within the substantia nigra pars compacta and the presence of protein aggregates in surviving neurons. The LRRK2 G2019S mutation is one of the major determinants of familial Parkinson’s disease cases and leads to late-onset Parkinson’s disease with pleomorphic pathology, including α-synuclein accumulation and deposition of protein inclusions. We demonstrated that LRRK2 phosphorylates N-ethylmaleimide sensitive factor (NSF). We observed aggregates containing NSF in basal ganglia specimens from patients with Parkinson’s disease carrying the G2019S variant, and in cellular and animal models expressing the LRRK2 G2019S variant. We found that LRRK2 G2019S kinase activity induces the accumulation of NSF in toxic aggregates. Of note, the induction of autophagy cleared NSF aggregation and rescued motor and cognitive impairment observed in aged hG2019S bacterial artificial chromosome (BAC) mice. We suggest that LRRK2 G2019S pathological phosphorylation impacts on NSF biochemical properties, thus causing the formation of cytotoxic protein inclusions.
Archive Staff Only
 |
View Item |
